biOasis Technologies, Inc. operates as a biopharmaceutical company. It focuses on research and development for the diagnosis and treatment of neurological disease and disorders such as brain cancers, neurodegenerative diseases, and metabolic disorders. Its products include the Transcend program as its proprietary carrier, p97 and imaging agents across the blood brain barrier. The company was founded by Robin B. Hutchison on November 3, 2006 and is headquartered in New Haven, CT.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Bioasis Technologies Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Bioasis Technologies Inc market cap is $397,070.00.
What is the 52-week high for Bioasis Technologies Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Bioasis Technologies Inc 52 week high is $0.0006 as of October 10, 2025.
What is the 52-week low for Bioasis Technologies Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Bioasis Technologies Inc 52 week low is $0.00 as of October 10, 2025.
What is Bioasis Technologies Inc stock price today?
Bioasis Technologies Inc stock price today is $0.0002.
What was Bioasis Technologies Inc stock price yesterday?
Bioasis Technologies Inc stock price yesterday was $0.0006.
What is the 50-day moving average of Bioasis Technologies Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Bioasis Technologies Inc 50-day moving average is $0.0001.